CHEMOCENTRYX INC's ticker is CCXI and the CUSIP is 16383L106. A total of 180 filers reported holding CHEMOCENTRYX INC in Q1 2022. The put-call ratio across all filers is 0.75 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $362,000 | -17.9% | 7,000 | -42.1% | 0.00% | 0.0% |
| Q4 2021 | $441,000 | +113.0% | 12,100 | 0.0% | 0.00% | +100.0% |
| Q3 2021 | $207,000 | +27.8% | 12,100 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $162,000 | -72.7% | 12,100 | +4.3% | 0.00% | -66.7% |
| Q1 2021 | $594,000 | -17.3% | 11,600 | 0.0% | 0.00% | -25.0% |
| Q4 2020 | $718,000 | +72.6% | 11,600 | +52.6% | 0.00% | +33.3% |
| Q3 2020 | $416,000 | -52.4% | 7,600 | -50.0% | 0.00% | -25.0% |
| Q2 2020 | $874,000 | – | 15,200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tri Locum Partners LP | 296,327 | $7,429,000 | 2.90% |
| Integral Health Asset Management, LLC | 400,000 | $10,028,000 | 2.61% |
| Cormorant Asset Management, LP | 865,000 | $21,686,000 | 1.66% |
| HealthCor Management, L.P. | 956,740 | $23,985,000 | 1.60% |
| Sofinnova Investments, Inc. | 573,684 | $14,382,000 | 1.09% |
| Lisanti Capital Growth, LLC | 321,569 | $8,062,000 | 0.91% |
| Cahill Wealth Management, LLC | 44,913 | $1,125,000 | 0.84% |
| Perceptive Advisors | 1,655,079 | $41,493,000 | 0.83% |
| RA Capital Management | 1,155,964 | $28,980,000 | 0.63% |
| Avidity Partners Management LP | 1,175,000 | $29,457,000 | 0.61% |